Vancouver-based Absci marks major milestone in partnership with ...
1 day ago · The company reported Tuesday it brought in $1.7 million in its third quarter of 2024, up from $700,000 in the third quarter of 2023. It also reported a $27.4 million net loss, 24 cents per diluted ...
Absci Corporation Advances AI-Driven Drug Development
1 day ago · Absci Corp. ( (ABSI)) has released its Q3 earnings. Here is a breakdown of the information Absci Corp. presented to its investors. Absci Corporation, a data-first generative AI drug creation ...
Absci Reports Business Updates and Third Quarter 2024 Financial …
1 day ago · Absci will host a conference call to discuss its third quarter 2024 business updates and financial and operating results on Tuesday, November 12, 2024 at 8:00 a.m. Eastern Time / 5:00 a.m. Pacific ...
Absci Reports Business Updates and Third Quarter 2024 Financial …
2 days ago · Cash, cash equivalents, and short-term investments as of September 30, 2024 were $127.1 million, compared to $145.2 million as of June 30, 2024. Absci will host a conference call to discuss its third quarter 2024 business updates and financial and operating results on Tuesday, November 12, 2024 at 8:00 a.m. Eastern Time / 5:00 a.m. Pacific Time.
Absci Corp (ABSI) Q3 2024 Earnings Call Highlights: Strategic ...
1 day ago · GuruFocus News. Wed, Nov 13, 2024, 2:07 AM3 min read. In This Article: ABSI. Revenue:$1.7 million for Q3 2024. Research and Development Expenses:$18 million for Q3 2024, up from $11 million in the ...
News releases - Absci Corp
VANCOUVER, Wash. and NEW YORK, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the following upcoming investor conferences.
News Release Details - Absci Corp
VANCOUVER, Wash., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a leader in generative AI antibody discovery, today announced a collaboration with AstraZeneca, a global biopharmaceutical company, to deliver an AI-designed antibody against an oncology target.
Q3 2024 Absci Corp Earnings Call - Yahoo Finance
1 day ago · Earlier today, Absci released financial and operating results for the quarter ended September 30 2024. If you haven't received this news release or if you would like to be added to the company's ...
Supplier-Turned-Partner: Twist Joins Absci in AI Antibody …
6 days ago · November 7, 2024. Absci has reached out to its preferred supplier of DNA, Twist Bioscience, for its latest collaboration. The companies have agreed to apply Twist’s silicon-based high-throughput ...
With $86M Oversubscribed Public Offering, Absci Eyes 2025 IND …
Mar 6, 2024 · Absci says it is about a year away from its lead AI-designed therapeutic entering the clinic—one of several pipeline candidates whose development the company says it will be better able to fund...
- Some results have been removed